SynthesisObesity surgery2025
Five-Year Outcomes of Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy: A Systematic Review.
Synthesis in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transient intussusception following single anastomosis duodeno-ileal (SADI) bypass surgery: case report and literature review.Journal of surgical case reports · 2026Article
- Recent Advances in Metabolic and Bariatric Surgery: A Narrative Review of Therapeutic Strategies for Weight Loss and Metabolic Health.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSingle Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S) has gained increasing popularity in bariatric surgery due to its promising weight loss and metabolic outcomes. However, long-term evidence remains limited. This systematic review aimed to assess the 5-year outcomes of SADI-S performed as a primary bariatric procedure, focusing on weight loss, morbidity, mortality, and complications.
methodsA systematic literature search was conducted in accordance with PRISMA guidelines. Out of 13 studies identified, four met the inclusion criteria. These studies reported outcomes of SADI-S as a primary bariatric procedure with follow-up at 5 years.
resultsThe included studies comprised 1088 patients across four centers. The mean preoperative BMI was 49.66 kg/m
conclusionsSADI-S appears to be an effective bariatric procedure, providing sustained weight loss and acceptable complication rates at 5 years. Its safety profile is comparable to other bariatric techniques. Nonetheless, nutritional risks-particularly those related to protein malnutrition-highlight the importance of structured postoperative monitoring. Further prospective studies are needed to validate these findings and guide surgical decision-making.
Indexed as
Identifiers
40730921What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.